设为首页 |  加入收藏
首页期刊介绍编委会投稿须知通知公告刊登文章继续教育园地协办单位联系我们广告合作
公告栏:
清开灵联合葡醛酸钠治疗病毒性乙型肝炎的临床研究
作者:李冬华 
单位:广东紫金县中医院,广东河源517400
关键词:清开灵 葡醛酸钠 病毒性乙型肝炎 
中图分类号:R285
文献标志码:A
出版年,卷(期):页码:2012,22(1):41-43,
收稿日期:2011 -10 -22
摘要:
目的观察清开灵联合葡醛酸钠治疗病毒性乙型肝炎的临床疗效。方法随机将80 例病毒性乙肝患者均分成2 组,对照组每日1 次静脉滴注清开灵注射液40 ml + 250 ml 生理盐水,实验组除清开灵外,还每日1 次静脉滴注葡醛酸钠0. 532 g + 10% 葡萄糖250ml,疗程均为30 d。结果治疗组总有效率72. 5%,对照组50. 0%;治疗组治疗后AST、ALT、TBIL 活力均较对照组治疗后显著降低,差异均有统计学意义(P <0. 05);症状体征明显改善。结论清开灵联合葡醛酸钠治疗病毒性乙型肝炎疗效稳定可靠,副作用少,有临床普及推广价值。
To observe the effects of Hepatitis B treated by Qingkailing and sodium glucuronate.Methods Eighty cases with Hepatitis B were randomly divided into 2 groups ( n = 40). Patients in the control group received 40 ml Qingkailing injection which were added in 250 ml physiological saline once a day. Besides Qingkailing injection, patients in the treatment group also received 0. 532 g sodium glucuronate which were added in 250 ml 10% glucose solution once a day. The course of treatment in both groups were 30 d. Results Total effective rate were 72. 5% nd 50.0% in treatment group and control group, respectively. Compared with control group, the values of AST, ALT and TBI in treatment group declined significantly, symptom and signs had remarkably improved. Conclusion The effect of Hepatitis B treated by Qingkailing combined with sodium glucuronate were stable and reliable, and with less side-effect, and possessed of popularization and application value.
基金项目:
作者简介:
李冬华,主管药师,Tel:18211251221,E-mail:HYZJLDH@126. com
通讯作者:
参考文献:
[1] 国家中医药管理局. 中成药临床应用指导原则[Z].国中医药医政发[2010] 3 号,2010.
[2] 王立军,周雪琴. 本院405 例药品不良反应报告分析[J]. 中国药房,2007,18(2)∶137 -138.
[3] 任长友. 中成药注射剂的合理应用[J]. 中国农村卫生事业管理,2008,28(7)∶559.
[4] 苏新民. 中成药注射剂致过敏反应初探[J]. 医学信息,2010,23(24)∶21 -22.
[5] 肖贵南,程朝辉,陈浩桉,等. 中成药注射剂引起的过敏反应及其检测技术[J]. 广东药学院学报,2009,25(6)∶636 -638.
[6] 龙丽萍,周于禄, 阳国平,等. 309 例老年人严重药品不良反应报告分析[J]. 中国药物警戒,2009,6(1)∶26 -30.
[7] 张荃钦. 关于中成药注射剂用药安全性的思考[J]. 中国民族民间医药,2010,16∶33 -34.
[8] 沈正林. 2008 年上半年本院中成药处方分析[J]. 基层医学论坛,2009,13(3)∶25 -26.
服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
 
友情链接  
广东今日药学杂志社有限公司   地址:广州市东风东路753号东塔7楼702
电话:020-37886325       邮箱:jinriyaoxue@163.com
本系统由北京博思汇文数字科技有限公司设计开发 技术服务电话:400-921-9838
粤ICP备20054928号

粤公网安备 44010402002138号

您是第 165216 位访问者